메뉴 건너뛰기




Volumn 29, Issue 14, 2011, Pages 1812-1826

Molecular pathogenesis of hodgkin's lymphoma: Increasing evidence of the importance of the microenvironment

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; AUTOCRINE MOTILITY FACTOR RECEPTOR; BORTEZOMIB; BRENTUXIMAB VEDOTIN; CHEMOKINE; CONATUMUMAB; CYTOKINE; EVEROLIMUS; GALIXIMAB; GEMCITABINE; IBRITUMOMAB TIUXETAN; IRATUMUMAB; LENALIDOMIDE; LUCATUMUMAB; PANOBINOSTAT; RITUXIMAB; TOSITUMOMAB I 131; TUMOR MARKER; VORINOSTAT;

EID: 79955877897     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.8401     Document Type: Review
Times cited : (305)

References (214)
  • 4
    • 4544247638 scopus 로고    scopus 로고
    • Hodgkin's lymphoma: Biology and treatment strategies for primary, refractory, and relapsed disease
    • Diehl V, Stein H, Hummel M, et al: Hodgkin's lymphoma: Biology and treatment strategies for primary, refractory, and relapsed disease. Hematology Am Soc Hematol Educ Program 225-247, 2003
    • (2003) Hematology Am Soc Hematol Educ Program , pp. 225-247
    • Diehl, V.1    Stein, H.2    Hummel, M.3
  • 5
    • 0032548107 scopus 로고    scopus 로고
    • A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease
    • Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339:1506-1514, 1998
    • (1998) N Engl J Med , vol.339 , pp. 1506-1514
    • Hasenclever, D.1    Diehl, V.2
  • 6
    • 77956646155 scopus 로고    scopus 로고
    • Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma
    • Engert A, Plutschow A, Eich HT, et al: Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med 363:640-652, 2010
    • (2010) N Engl J Med , vol.363 , pp. 640-652
    • Engert, A.1    Plutschow, A.2    Eich, H.T.3
  • 7
    • 77949355797 scopus 로고    scopus 로고
    • Toward a personalized treatment of Hodgkin's disease
    • DeVita VT Jr, Costa J: Toward a personalized treatment of Hodgkin's disease. N Engl J Med 362:942-943, 2010
    • (2010) N Engl J Med , vol.362 , pp. 942-943
    • DeVita Jr., V.T.1    Costa, J.2
  • 8
    • 0037097818 scopus 로고    scopus 로고
    • The role of cytokines in classical Hodgkin lymphoma
    • DOI 10.1182/blood-2002-01-0099
    • Skinnider BF, Mak TW: The role of cytokines in classical Hodgkin lymphoma. Blood 99:4283-4297, 2002 (Pubitemid 34627193)
    • (2002) Blood , vol.99 , Issue.12 , pp. 4283-4297
    • Skinnider, B.F.1    Mak, T.W.2
  • 10
    • 33645227964 scopus 로고    scopus 로고
    • Epstein-Barr virus, cytokines, and inflammation: A cocktail for the pathogenesis of Hodgkin's lymphoma?
    • Khan G: Epstein-Barr virus, cytokines, and inflammation: A cocktail for the pathogenesis of Hodgkin's lymphoma? Exp Hematol 34:399-406, 2006
    • (2006) Exp Hematol , vol.34 , pp. 399-406
    • Khan, G.1
  • 12
    • 0027101947 scopus 로고
    • Production of multiple cytokines by Hodgkin's disease derived cell lines
    • Klein S, Jucker M, Diehl V, et al: Production of multiple cytokines by Hodgkin's disease derived cell lines. Hematol Oncol 10:319-329, 1992 (Pubitemid 23101130)
    • (1992) Hematological Oncology , vol.10 , Issue.6 , pp. 319-329
    • Klein, S.1    Jucker, M.2    Diehl, V.3    Tesch, H.4
  • 13
    • 42549166115 scopus 로고    scopus 로고
    • The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile
    • DOI 10.1038/labinvest.2008.24, PII LABINVEST200824
    • Ma Y, Visser L, Blokzijl T, et al: The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile. Lab Invest 88:482-490, 2008 (Pubitemid 351581458)
    • (2008) Laboratory Investigation , vol.88 , Issue.5 , pp. 482-490
    • Ma, Y.1    Visser, L.2    Blokzijl, T.3    Harms, G.4    Atayar, C.5    Poppema, S.6    Van Den, B.A.7
  • 14
    • 0028961649 scopus 로고
    • Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders
    • Schwaller J, Tobler A, Niklaus G, et al: Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders. Blood 85:2182-2188, 1995
    • (1995) Blood , vol.85 , pp. 2182-2188
    • Schwaller, J.1    Tobler, A.2    Niklaus, G.3
  • 15
    • 0025461832 scopus 로고
    • Immunoenzymatic assessment of interferon-gamma in Hodgkin and Sternberg-Reed cells
    • Gerdes J, Kretschmer C, Zahn G, et al: Immunoenzymatic assessment of interferon-gamma in Hodgkin and Sternberg-Reed cells. Cytokine 2:307-310, 1990
    • (1990) Cytokine , vol.2 , pp. 307-310
    • Gerdes, J.1    Kretschmer, C.2    Zahn, G.3
  • 16
    • 0033560818 scopus 로고    scopus 로고
    • Differential chemokine expression in tissues involved by Hodgkin's disease: Direct correlation of eotaxin expression and tissue eosinophilia
    • Teruya-Feldstein J, Jaffe ES, Burd PR, et al: Differential chemokine expression in tissues involved by Hodgkin's disease: Direct correlation of eotaxin expression and tissue eosinophilia. Blood 93:2463-2470, 1999 (Pubitemid 29181176)
    • (1999) Blood , vol.93 , Issue.8 , pp. 2463-2470
    • Teruya-Feldstein, J.1    Jaffe, E.S.2    Burd, P.R.3    Kingma, D.W.4    Setsuda, J.E.5    Tosato, G.6
  • 17
    • 0027278569 scopus 로고
    • Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms
    • Kurzrock R, Redman J, Cabanillas F, et al: Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res 53:2118-2122, 1993 (Pubitemid 23145736)
    • (1993) Cancer Research , vol.53 , Issue.9 , pp. 2118-2122
    • Kurzrock, R.1    Redman, J.2    Cabanillas, F.3    Jones, D.4    Rothberg, J.5    Talpaz, M.6
  • 18
    • 0033591689 scopus 로고    scopus 로고
    • Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells
    • Kapp U, Yeh WC, Patterson B, et al: Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med 189: 1939-1946, 1999
    • (1999) J Exp Med , vol.189 , pp. 1939-1946
    • Kapp, U.1    Yeh, W.C.2    Patterson, B.3
  • 19
    • 0025021864 scopus 로고
    • Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia
    • Samoszuk M, Nansen L: Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 75:13-16, 1990 (Pubitemid 20031482)
    • (1990) Blood , vol.75 , Issue.1 , pp. 13-16
    • Samoszuk, M.1    Nansen, L.2
  • 20
    • 0028309999 scopus 로고
    • The nature of Reed- Sternberg cells: Phenotype, genotype, and other properties
    • Hsu SM, Hsu PL: The nature of Reed- Sternberg cells: Phenotype, genotype, and other properties. Crit Rev Oncog 5:213-245, 1994
    • (1994) Crit Rev Oncog , vol.5 , pp. 213-245
    • Hsu, S.M.1    Hsu, P.L.2
  • 22
    • 0026043718 scopus 로고
    • Cytokine expression in T-cell lymphomas and Hodgkin's disease: Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth
    • Merz H, Fliedner A, Orscheschek K, et al: Cytokine expression in T-cell lymphomas and Hodgkin's disease: Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am J Pathol 139:1173-1180, 1991
    • (1991) Am J Pathol , vol.139 , pp. 1173-1180
    • Merz, H.1    Fliedner, A.2    Orscheschek, K.3
  • 23
    • 0026048748 scopus 로고
    • Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma
    • Merz H, Houssiau FA, Orscheschek K, et al: Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78:1311-1317, 1991
    • (1991) Blood , vol.78 , pp. 1311-1317
    • Merz, H.1    Houssiau, F.A.2    Orscheschek, K.3
  • 24
    • 33644840611 scopus 로고    scopus 로고
    • IL-9 expression contributes to the cellular composition in Hodgkin lymphoma
    • Glimelius I, Edstrom A, Amini RM, et al: IL-9 expression contributes to the cellular composition in Hodgkin lymphoma. Eur J Haematol 76:278-283, 2006
    • (2006) Eur J Haematol , vol.76 , pp. 278-283
    • Glimelius, I.1    Edstrom, A.2    Amini, R.M.3
  • 26
    • 11144233653 scopus 로고    scopus 로고
    • Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas
    • Atayar C, Poppema S, Blokzijl T, et al: Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas. Am J Pathol 166:127-134, 2005 (Pubitemid 40051666)
    • (2005) American Journal of Pathology , vol.166 , Issue.1 , pp. 127-134
    • Atayar, C.1    Poppema, S.2    Blokzijl, T.3    Harms, G.4    Boot, M.5    Van Den, B.A.6
  • 29
    • 0035525784 scopus 로고    scopus 로고
    • Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines
    • Fiumara P, Snell V, Li Y, et al: Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood 98:2784-2790, 2001
    • (2001) Blood , vol.98 , pp. 2784-2790
    • Fiumara, P.1    Snell, V.2    Li, Y.3
  • 31
    • 0034651829 scopus 로고    scopus 로고
    • Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors
    • von Wasielewski R, Seth S, Franklin J, et al: Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood 95:1207-1213, 2000 (Pubitemid 30099828)
    • (2000) Blood , vol.95 , Issue.4 , pp. 1207-1213
    • Von Wasielewski, R.1    Seth, S.2    Franklin, J.3    Fischer, R.4    Hubner, K.5    Hansmann, M.L.6    Diehl, V.7    Georgii, A.8
  • 32
    • 0036110322 scopus 로고    scopus 로고
    • Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical Hodgkin lymphomas
    • Maggio EM, Van Den Berg A, Visser L, et al: Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical Hodgkin lymphomas. Int J Cancer 99:665-672, 2002
    • (2002) Int J Cancer , vol.99 , pp. 665-672
    • Maggio, E.M.1    Van Den Berg, A.2    Visser, L.3
  • 33
    • 0026597091 scopus 로고
    • In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease
    • Xerri L, Birg F, Guigou V, et al: In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease. Int J Cancer 50:689-693, 1992
    • (1992) Int J Cancer , vol.50 , pp. 689-693
    • Xerri, L.1    Birg, F.2    Guigou, V.3
  • 35
    • 0023263077 scopus 로고
    • Anti-interleukin-1 reactive cells in Hodgkin's disease
    • DOI 10.1002/1097-0142(19870515)59:10<1717::AID-CNCR2820591007>3.0. CO;2-U
    • Ree HJ, Crowley JP, Dinarello CA: Anti-interleukin- 1 reactive cells in Hodgkin's disease. Cancer 59:1717-1720, 1987 (Pubitemid 17075416)
    • (1987) Cancer , vol.59 , Issue.10 , pp. 1717-1720
    • Ree, H.J.1    Crowley, J.P.2    Dinarello, C.A.3
  • 36
    • 0027513352 scopus 로고
    • Abundant expression of transforming growth factor-beta1 and -beta2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease
    • DOI 10.1016/0046-8177(93)90034-E
    • Hsu SM, Lin J, Xie SS, et al: Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease. Hum Pathol 24:249-255, 1993 (Pubitemid 23086359)
    • (1993) Human Pathology , vol.24 , Issue.3 , pp. 249-255
    • Hsu, S.-M.1    Lin, J.2    Xie, S.-S.3    Hsu, P.-L.4    Rich, S.5
  • 41
    • 32244441965 scopus 로고    scopus 로고
    • The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma
    • DOI 10.1002/path.1900
    • Khnykin D, Troen G, Berner JM, et al: The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma. J Pathol 208:431-438, 2006 (Pubitemid 43210531)
    • (2006) Journal of Pathology , vol.208 , Issue.3 , pp. 431-438
    • Khnykin, D.1    Troen, G.2    Berner, J.-M.3    Delabie, J.4
  • 43
    • 0025737623 scopus 로고
    • Expression of macrophage colony-stimulating factor (M-CSF) in two Hodgkin's Reed-Sternberg (H-RS) cell lines, HDLM-1 and KM-H2, and in H-RS cells in tissues
    • Hsu PL, Lin YC, Hsu SM: Expression of macrophage colony-stimulating factor (M-CSF) in two Hodgkin's Reed-Sternberg (H-RS) cell lines, HDLM-1 and KM-H2, and in H-RS cells in tissues. Int J Hematol 54:315-326, 1991
    • (1991) Int J Hematol , vol.54 , pp. 315-326
    • Hsu, P.L.1    Lin, Y.C.2    Hsu, S.M.3
  • 44
    • 77952190003 scopus 로고    scopus 로고
    • Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma
    • Lamprecht B, Walter K, Kreher S, et al: Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med 16:571-579, 2010
    • (2010) Nat Med , vol.16 , pp. 571-579
    • Lamprecht, B.1    Walter, K.2    Kreher, S.3
  • 46
    • 0141634201 scopus 로고    scopus 로고
    • Expression of CCL5/RANTES by Hodgkin and Reed- Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue
    • Fischer M, Juremalm M, Olsson N, et al: Expression of CCL5/RANTES by Hodgkin and Reed- Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int J Cancer 107:197-201, 2003
    • (2003) Int J Cancer , vol.107 , pp. 197-201
    • Fischer, M.1    Juremalm, M.2    Olsson, N.3
  • 47
    • 0035869293 scopus 로고    scopus 로고
    • CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease
    • DOI 10.1182/blood.V97.6.1543
    • Buri C, Korner M, Scharli P, et al: CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease. Blood 97:1543-1548, 2001 (Pubitemid 32217213)
    • (2001) Blood , vol.97 , Issue.6 , pp. 1543-1548
    • Buri, C.1    Korner, M.2    Scharli, P.3    Cefai, D.4    Uguccioni, M.5    Mueller, C.6    Laissue, J.A.7    Mazzucchelli, L.8
  • 49
    • 0033058533 scopus 로고    scopus 로고
    • High expression of the CC chemokine TARC in Reed- Sternberg cells: A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma
    • van den Berg A, Visser L, Poppema S: High expression of the CC chemokine TARC in Reed- Sternberg cells: A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am J Pathol 154:1685-1691, 1999
    • (1999) Am J Pathol , vol.154 , pp. 1685-1691
    • Van Den Berg, A.1    Visser, L.2    Poppema, S.3
  • 50
    • 0036533604 scopus 로고    scopus 로고
    • Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells
    • DOI 10.1002/ijc.10218
    • Ohshima K, Tutiya T, Yamaguchi T, et al: Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells. Int J Cancer 98:567-572, 2002 (Pubitemid 34208558)
    • (2002) International Journal of Cancer , vol.98 , Issue.4 , pp. 567-572
    • Ohshima, K.1    Tutiya, T.2    Yamaguchi, T.3    Suzuki, K.4    Suzumiya, J.5    Kawasaki, C.6    Haraoka, S.7    Kikuchi, M.8
  • 51
    • 0034962511 scopus 로고    scopus 로고
    • TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma
    • DOI 10.1097/00000478-200107000-00011
    • Peh SC, Kim LH, Poppema S: TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Am J Surg Pathol 25:925-929, 2001 (Pubitemid 32594986)
    • (2001) American Journal of Surgical Pathology , vol.25 , Issue.7 , pp. 925-929
    • Peh, S.C.1    Kim, L.H.2    Poppema, S.3
  • 53
    • 0029964093 scopus 로고    scopus 로고
    • Interleukin-8 in Hodgkin's disease: Preferential expression by reactive cells and association with neutrophil density
    • Foss HD, Herbst H, Gottstein S, et al: Interleukin-8 in Hodgkin's disease: Preferential expression by reactive cells and association with neutrophil density. Am J Pathol 148:1229-1236, 1996 (Pubitemid 26108258)
    • (1996) American Journal of Pathology , vol.148 , Issue.4 , pp. 1229-1236
    • Foss, H.-D.1    Herbst, H.2    Gottstein, S.3    Demel, G.4    Araujo, I.5    Stein, H.6
  • 55
    • 0028029111 scopus 로고
    • Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease
    • Trumper L, Jung W, Dahl G, et al: Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease. Ann Oncol 5:93-96, 1994 (suppl 1) (Pubitemid 24051326)
    • (1994) Annals of Oncology , vol.5 , Issue.SUPPL. 1 , pp. 93-96
    • Trumper, L.1    Jung, W.2    Dahl, G.3    Diehl, V.4    Gause, A.5    Pfreundschuh, M.6
  • 56
    • 0029029088 scopus 로고
    • Serum cytokine levels correlate with clinical parameters in Hodgkin's disease
    • Gorschlüter M, Bohlen H, Hasenclever D, et al: Serum cytokine levels correlate with clinical parameters in Hodgkin's disease. Ann Oncol 6:477-482, 1995
    • (1995) Ann Oncol , vol.6 , pp. 477-482
    • Gorschlüter, M.1    Bohlen, H.2    Hasenclever, D.3
  • 57
    • 0037082511 scopus 로고    scopus 로고
    • Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs
    • DOI 10.1182/blood.V99.4.1109
    • Hopken UE, Foss HD, Meyer D, et al: Upregulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood 99:1109-1116, 2002 (Pubitemid 34547061)
    • (2002) Blood , vol.99 , Issue.4 , pp. 1109-1116
    • Hopken, U.E.1    Foss, H.-D.2    Meyer, D.3    Hinz, M.4    Leder, K.5    Stein, H.6    Lipp, M.7
  • 58
    • 0020074168 scopus 로고
    • In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease
    • Poppema S, Bhan AK, Reinherz EL, et al: In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease. Blood 59:226-232, 1982
    • (1982) Blood , vol.59 , pp. 226-232
    • Poppema, S.1    Bhan, A.K.2    Reinherz, E.L.3
  • 59
    • 0030067451 scopus 로고    scopus 로고
    • CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets
    • Poppema S, Lai R, Visser L, et al: CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets. Leuk Lymphoma 20:217-222, 1996
    • (1996) Leuk Lymphoma , vol.20 , pp. 217-222
    • Poppema, S.1    Lai, R.2    Visser, L.3
  • 60
    • 0031803784 scopus 로고    scopus 로고
    • Cytokines in hematopoiesis
    • Alexander WS: Cytokines in hematopoiesis. Int Rev Immunol 16:651-682, 1998
    • (1998) Int Rev Immunol , vol.16 , pp. 651-682
    • Alexander, W.S.1
  • 61
    • 58149398634 scopus 로고    scopus 로고
    • CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis
    • Truman LA, Ford CA, Pasikowska M, et al: CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 112:5026-5036, 2008
    • (2008) Blood , vol.112 , pp. 5026-5036
    • Truman, L.A.1    Ford, C.A.2    Pasikowska, M.3
  • 62
    • 77950950894 scopus 로고    scopus 로고
    • Macrophage diversity enhances tumor progression and metastasis
    • Qian BZ, Pollard JW: Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51, 2010
    • (2010) Cell , vol.141 , pp. 39-51
    • Qian, B.Z.1    Pollard, J.W.2
  • 63
    • 5144224056 scopus 로고    scopus 로고
    • Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies
    • DOI 10.1182/blood-2004-03-0890
    • Stein R, Qu Z, Cardillo TM, et al: Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies. Blood 104:3705-3711, 2004 (Pubitemid 39564448)
    • (2004) Blood , vol.104 , Issue.12 , pp. 3705-3711
    • Stein, R.1    Qu, Z.2    Cardillo, T.M.3    Chen, S.4    Rosario, A.5    Horak, I.D.6    Hansen, H.J.7    Goldenberg, D.M.8
  • 65
    • 0035570881 scopus 로고    scopus 로고
    • Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: Possible autocrine mechanism and involvement in fibrosis
    • DOI 10.1046/j.1365-2559.2001.01083.x
    • Ohshima K, Akaiwa M, Umeshita R, et al: Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: Possible autocrine mechanism and involvement in fibrosis. Histopathology 38:368-375, 2001 (Pubitemid 34225031)
    • (2001) Histopathology , vol.38 , Issue.4 , pp. 368-375
    • Ohshima, K.1    Akaiwa, M.2    Umeshita, R.3    Suzumiya, J.4    Izuhara, K.5    Kikuchi, M.6
  • 66
    • 42149168527 scopus 로고    scopus 로고
    • ICOS, CD40, and lymphotoxin beta receptors signal sequentially and interdependently to initiate a germinal center reaction
    • Vu F, Dianzani U, Ware CF, et al: ICOS, CD40, and lymphotoxin beta receptors signal sequentially and interdependently to initiate a germinal center reaction. J Immunol 180:2284-2293, 2008
    • (2008) J Immunol , vol.180 , pp. 2284-2293
    • Vu, F.1    Dianzani, U.2    Ware, C.F.3
  • 67
    • 49249095467 scopus 로고    scopus 로고
    • PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma
    • Nam-Cha SH, Roncador G, Sanchez-Verde L, et al: PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 32:1252-1257, 2008
    • (2008) Am J Surg Pathol , vol.32 , pp. 1252-1257
    • Nam-Cha, S.H.1    Roncador, G.2    Sanchez-Verde, L.3
  • 68
    • 57749171165 scopus 로고    scopus 로고
    • The biology of Hodgkin's lymphoma
    • Küppers R: The biology of Hodgkin's lymphoma. Nat Rev Cancer 9:15-27, 2009
    • (2009) Nat Rev Cancer , vol.9 , pp. 15-27
    • Küppers, R.1
  • 72
    • 77955866440 scopus 로고    scopus 로고
    • Genomewide copy number analysis of Hodgkin Reed- Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
    • Steidl C, Telenius A, Shah SP, et al: Genomewide copy number analysis of Hodgkin Reed- Sternberg cells identifies recurrent imbalances with correlations to treatment outcome. Blood 116:418-427, 2010
    • (2010) Blood , vol.116 , pp. 418-427
    • Steidl, C.1    Telenius, A.2    Shah, S.P.3
  • 74
    • 33745619800 scopus 로고    scopus 로고
    • Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma
    • author reply 402-403
    • Martin-Subero JI, Wlodarska I, Bastard C, et al: Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma. Blood 108:401-402, 2006; author reply 402-403
    • (2006) Blood , vol.108 , pp. 401-402
    • Martin-Subero, J.I.1    Wlodarska, I.2    Bastard, C.3
  • 75
    • 0033587084 scopus 로고    scopus 로고
    • Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha
    • DOI 10.1038/sj.onc.1202893
    • Cabannes E, Khan G, Aillet F, et al: Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 18:3063-3070, 1999 (Pubitemid 29261226)
    • (1999) Oncogene , vol.18 , Issue.20 , pp. 3063-3070
    • Cabannes, E.1    Khan, G.2    Aillet, F.3    Jarrett, R.F.4    Hay, R.T.5
  • 77
    • 0034677104 scopus 로고    scopus 로고
    • Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma
    • Jungnickel B, Staratschek-Jox A, Bräuninger A, et al: Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 191:395-402, 2000
    • (2000) J Exp Med , vol.191 , pp. 395-402
    • Jungnickel, B.1    Staratschek-Jox, A.2    Bräuninger, A.3
  • 79
    • 66049124247 scopus 로고    scopus 로고
    • TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
    • Schmitz R, Hansmann ML, Bohle V, et al: TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 206:981-989, 2009
    • (2009) J Exp Med , vol.206 , pp. 981-989
    • Schmitz, R.1    Hansmann, M.L.2    Bohle, V.3
  • 80
    • 33646382121 scopus 로고    scopus 로고
    • Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation
    • Weniger MA, Melzner I, Menz CK, et al: Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 25:2679-2684, 2006
    • (2006) Oncogene , vol.25 , pp. 2679-2684
    • Weniger, M.A.1    Melzner, I.2    Menz, C.K.3
  • 81
    • 36148989576 scopus 로고    scopus 로고
    • Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6
    • DOI 10.1182/blood-2007-03-082511
    • Mottok A, Renné C, Willenbrock K, et al: Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. Blood 110:3387-3390, 2007 (Pubitemid 350106334)
    • (2007) Blood , vol.110 , Issue.9 , pp. 3387-3390
    • Mottok, A.1    Renne, C.2    Willenbrock, K.3    Hansmann, M.-L.4    Brauninger, A.5
  • 82
    • 0035479946 scopus 로고    scopus 로고
    • TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus
    • DOI 10.1002/ijc.1438
    • Maggio EM, Stekelenburg E, Van den Berg A, et al: TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus. Int J Cancer 94:60-66, 2001 (Pubitemid 32801753)
    • (2001) International Journal of Cancer , vol.94 , Issue.1 , pp. 60-66
    • Maggio, E.M.1    Stekelenburg, E.2    Van Berg, A.D.3    Poppema, S.4
  • 83
    • 0035315880 scopus 로고    scopus 로고
    • Role of Jak kinases and STATs in cytokine signal transduction
    • Leonard WJ: Role of Jak kinases and STATs in cytokine signal transduction. Int J Hematol 73:271-277, 2001
    • (2001) Int J Hematol , vol.73 , pp. 271-277
    • Leonard, W.J.1
  • 84
    • 61849157254 scopus 로고    scopus 로고
    • TNFR signaling: Ubiquitin-conjugated TRAFfic signals control stop-and- Go for MAPK signaling complexes
    • Karin M, Gallagher E: TNFR signaling: Ubiquitin-conjugated TRAFfic signals control stop-and- go for MAPK signaling complexes. Immunol Rev 228:225-240, 2009
    • (2009) Immunol Rev , vol.228 , pp. 225-240
    • Karin, M.1    Gallagher, E.2
  • 85
    • 0037032835 scopus 로고    scopus 로고
    • The protein kinase complement of the human genome
    • Manning G, Whyte DB, Martinez R, et al: The protein kinase complement of the human genome. Science 298:1912-1934, 2002
    • (2002) Science , vol.298 , pp. 1912-1934
    • Manning, G.1    Whyte, D.B.2    Martinez, R.3
  • 86
    • 0028857781 scopus 로고
    • CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease
    • Carbone A, Gloghini A, Gruss HJ, et al: CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 147:912-922, 1995
    • (1995) Am J Pathol , vol.147 , pp. 912-922
    • Carbone, A.1    Gloghini, A.2    Gruss, H.J.3
  • 88
    • 0032536860 scopus 로고    scopus 로고
    • Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor
    • DOI 10.1093/emboj/17.6.1700
    • Kilger E, Kieser A, Baumann M, et al: Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. Embo J 17:1700-1709, 1998 (Pubitemid 28119123)
    • (1998) EMBO Journal , vol.17 , Issue.6 , pp. 1700-1709
    • Kilger, E.1    Kieser, A.2    Baumann, M.3    Hammerschmidt, W.4
  • 90
    • 0037079728 scopus 로고    scopus 로고
    • Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Stenberg cells of Hodgkin lymphoma
    • DOI 10.1182/blood.V99.2.618
    • Skinnider BF, Elia AJ, Gascoyne RD, et al: Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 99:618-626, 2002 (Pubitemid 34533100)
    • (2002) Blood , vol.99 , Issue.2 , pp. 618-626
    • Skinnider, B.F.1    Elia, A.J.2    Gascoyne, R.D.3    Patterson, B.4    Trumper, L.5    Kapp, U.6    Mak, T.W.7
  • 91
    • 47149098995 scopus 로고    scopus 로고
    • IL-21 is expressed in Hodgkin lymphoma and activates STAT5: Evidence that activated STAT5 is required for Hodgkin lymphomagenesis
    • Scheeren FA, Diehl SA, Smit LA, et al: IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood 111:4706-4715, 2008
    • (2008) Blood , vol.111 , pp. 4706-4715
    • Scheeren, F.A.1    Diehl, S.A.2    Smit, L.A.3
  • 92
    • 0035437158 scopus 로고    scopus 로고
    • STAT3 is constitutively activated in Hodgkin cell lines
    • Kube D, Holtick U, Vockerodt M, et al: STAT3 is constitutively activated in Hodgkin cell lines. Blood 98:762-770, 2001
    • (2001) Blood , vol.98 , pp. 762-770
    • Kube, D.1    Holtick, U.2    Vockerodt, M.3
  • 93
    • 77953534075 scopus 로고    scopus 로고
    • The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape
    • Aldinucci D, Gloghini A, Pinto A, et al: The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. J Pathol 221:248-263, 2010
    • (2010) J Pathol , vol.221 , pp. 248-263
    • Aldinucci, D.1    Gloghini, A.2    Pinto, A.3
  • 96
    • 0025867022 scopus 로고
    • Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease
    • Jucker M, Abts H, Li W, et al: Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood 77:2413-2418, 1991
    • (1991) Blood , vol.77 , pp. 2413-2418
    • Jucker, M.1    Abts, H.2    Li, W.3
  • 97
    • 67650087810 scopus 로고    scopus 로고
    • Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma
    • Cattaruzza L, Gloghini A, Olivo K, et al: Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. Int J Cancer 125:1092-1101, 2009
    • (2009) Int J Cancer , vol.125 , pp. 1092-1101
    • Cattaruzza, L.1    Gloghini, A.2    Olivo, K.3
  • 98
    • 0032171594 scopus 로고    scopus 로고
    • Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines
    • DOI 10.1016/S0145-2126(98)00071-X, PII S014521269800071X
    • Pons E, Uphoff CC, Drexler HG: Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines. Leuk Res 22:797-804, 1998 (Pubitemid 28388957)
    • (1998) Leukemia Research , vol.22 , Issue.9 , pp. 797-804
    • Pons, E.1    Uphoff, C.C.2    Drexler, H.G.3
  • 100
    • 18544380247 scopus 로고    scopus 로고
    • Autocrine- And paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma
    • DOI 10.1182/blood-2004-10-4008
    • Renné C, Willenbrock K, Küppers R, et al: Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. Blood 105: 4051-4059, 2005 (Pubitemid 40656155)
    • (2005) Blood , vol.105 , Issue.10 , pp. 4051-4059
    • Renne, C.1    Willenbrock, K.2    Kuppers, R.3    Hansmann, M.-L.4    Brauninger, A.5
  • 102
    • 36049049415 scopus 로고    scopus 로고
    • Autocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines
    • DOI 10.1016/j.leukres.2007.05.019, PII S014521260700224X
    • Renné C, Minner S, Küppers R, et al: Autocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines. Leuk Res 32:163-167, 2008 (Pubitemid 350100851)
    • (2008) Leukemia Research , vol.32 , Issue.1 , pp. 163-167
    • Renne, C.1    Minner, S.2    Kuppers, R.3    Hansmann, M.-L.4    Brauninger, A.5
  • 104
  • 107
    • 38349059732 scopus 로고    scopus 로고
    • Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions
    • Aldinucci D, Lorenzon D, Cattaruzza L, et al: Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. Int J Cancer 122:769-776, 2008
    • (2008) Int J Cancer , vol.122 , pp. 769-776
    • Aldinucci, D.1    Lorenzon, D.2    Cattaruzza, L.3
  • 109
    • 0025297289 scopus 로고
    • Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease
    • Kadin ME, Agnarsson BA, Ellingsworth LR, et al: Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease. Am J Pathol 136:1209-1214, 1990 (Pubitemid 20210318)
    • (1990) American Journal of Pathology , vol.136 , Issue.6 , pp. 1209-1214
    • Kadin, M.E.1    Agnarsson, B.A.2    Ellingsworth, L.R.3    Newcom, S.R.4
  • 110
  • 111
    • 0027724464 scopus 로고
    • 2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation
    • Cayeux SJ, Beverley PC, Schulz R, et al: Elevated plasma prostaglandin E2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation. Bone Marrow Transplant 12:603-608, 1993 (Pubitemid 24020993)
    • (1993) Bone Marrow Transplantation , vol.12 , Issue.6 , pp. 603-608
    • Cayeux, S.J.1    Beverley, P.C.L.2    Schulz, R.3    Dorken, B.4
  • 112
  • 114
    • 0142147190 scopus 로고    scopus 로고
    • The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma
    • Kim LH, Eow GI, Peh SC, et al: The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma. Pathology 35:428-435, 2003
    • (2003) Pathology , vol.35 , pp. 428-435
    • Kim, L.H.1    Eow, G.I.2    Peh, S.C.3
  • 115
    • 0031570098 scopus 로고    scopus 로고
    • Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back
    • Walker PR, Saas P, Dietrich PY: Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back. J Immunol 158:4521-4524, 1997
    • (1997) J Immunol , vol.158 , pp. 4521-4524
    • Walker, P.R.1    Saas, P.2    Dietrich, P.Y.3
  • 120
    • 42449147063 scopus 로고    scopus 로고
    • PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
    • Yamamoto R, Nishikori M, Kitawaki T, et al: PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 111:3220-3224, 2008
    • (2008) Blood , vol.111 , pp. 3220-3224
    • Yamamoto, R.1    Nishikori, M.2    Kitawaki, T.3
  • 121
    • 78049370405 scopus 로고    scopus 로고
    • Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
    • Green MR, Monti S, Rodig SJ, et al: Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 116: 3268-3277, 2010
    • (2010) Blood , vol.116 , pp. 3268-3277
    • Green, M.R.1    Monti, S.2    Rodig, S.J.3
  • 124
    • 77956546059 scopus 로고    scopus 로고
    • Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients
    • Huang X, van den Berg A, Gao Z, et al: Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients. PLoS One 5:e10865, 2010
    • (2010) PLoS One , vol.5
    • Huang, X.1    Van Den Berg, A.2    Gao, Z.3
  • 125
    • 33646229918 scopus 로고    scopus 로고
    • Immunobiology and pathophysiology of Hodgkin lymphomas
    • Poppema S: Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program 231-238, 2005
    • (2005) Hematology Am Soc Hematol Educ Program , pp. 231-238
    • Poppema, S.1
  • 128
    • 77950902491 scopus 로고    scopus 로고
    • HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
    • Hjalgrim H, Rostgaard K, Johnson PC, et al: HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci U S A 107:6400-6405, 2010
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 6400-6405
    • Hjalgrim, H.1    Rostgaard, K.2    Johnson, P.C.3
  • 131
    • 63149134916 scopus 로고    scopus 로고
    • A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples
    • Sánchez-Espiridión B, Sánchez-Aguilera A, Montalbán C, et al: A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples. Clin Cancer Res 15:1367-1375, 2009
    • (2009) Clin Cancer Res , vol.15 , pp. 1367-1375
    • Sánchez-Espiridión, B.1    Sánchez-Aguilera, A.2    Montalbán, C.3
  • 132
    • 77949345555 scopus 로고    scopus 로고
    • Tumor-associated macrophages and survival in classic Hodgkin's lymphoma
    • Steidl C, Lee T, Shah SP, et al: Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 362:875-885, 2010
    • (2010) N Engl J Med , vol.362 , pp. 875-885
    • Steidl, C.1    Lee, T.2    Shah, S.P.3
  • 135
    • 0035084021 scopus 로고    scopus 로고
    • Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: An independent biological prognostic marker
    • ten Berge RL, Oudejans JJ, Dukers DF, et al: Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: An independent biological prognostic marker. Leukemia 15:458-464, 2001
    • (2001) Leukemia , vol.15 , pp. 458-464
    • Ten Berge, R.L.1    Oudejans, J.J.2    Dukers, D.F.3
  • 137
    • 38049022492 scopus 로고    scopus 로고
    • The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression
    • Kelley TW, Pohlman B, Elson P, et al: The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. Am J Clin Pathol 128:958-965, 2007
    • (2007) Am J Clin Pathol , vol.128 , pp. 958-965
    • Kelley, T.W.1    Pohlman, B.2    Elson, P.3
  • 139
    • 40849126992 scopus 로고    scopus 로고
    • + regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
    • DOI 10.3324/haematol.11702
    • Tzankov A, Meier C, Hirschmann P, et al: Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 93:193-200, 2008 (Pubitemid 351397707)
    • (2008) Haematologica , vol.93 , Issue.2 , pp. 193-200
    • Tzankov, A.1    Meier, C.2    Hirschmann, P.3    Went, P.4    Pileri, S.A.5    Dirnhofer, S.6
  • 140
    • 63849185609 scopus 로고    scopus 로고
    • Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome
    • Chetaille B, Bertucci F, Finetti P, et al: Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood 113:2765-3775, 2009
    • (2009) Blood , vol.113 , pp. 2765-3775
    • Chetaille, B.1    Bertucci, F.2    Finetti, P.3
  • 141
    • 0021796995 scopus 로고
    • Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophage-histiocytes to clinicopathologic presentation and course of disease
    • DOI 10.1002/1097-0142(19850715)56:2<333::AID-CNCR2820560222>3.0. CO;2-0
    • Ree HJ, Kadin ME: Macrophage-histiocytes in Hodgkin's disease: The relation of peanut-agglutinin- binding macrophage-histiocytes to clinico-pathologic presentation and course of disease. Cancer 56:333-338, 1985 (Pubitemid 15031656)
    • (1985) Cancer , vol.56 , Issue.2 , pp. 333-338
    • Ree, H.J.1    Kadin, M.E.2
  • 143
    • 0034019368 scopus 로고    scopus 로고
    • Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: Study of 47 South African cases
    • DOI 10.1136/jcp.53.3.182
    • Engel M, Essop MF, Close P, et al: Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: Study of 47 South African cases. J Clin Pathol 53:182-186, 2000 (Pubitemid 30163599)
    • (2000) Journal of Clinical Pathology , vol.53 , Issue.3 , pp. 182-186
    • Engel, M.1    Essop, M.F.2    Close, P.3    Hartley, P.4    Pallesen, G.5    Sinclair-Smith, C.6
  • 145
    • 68949088571 scopus 로고    scopus 로고
    • Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients
    • Diepstra A, van Imhoff GW, Schaapveld M, et al: Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. J Clin Oncol 27:3815-3821, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 3815-3821
    • Diepstra, A.1    Van Imhoff, G.W.2    Schaapveld, M.3
  • 146
    • 27144466008 scopus 로고    scopus 로고
    • Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study
    • DOI 10.1182/blood-2004-09-3759
    • Jarrett RF, Stark GL, White J, et al: Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study. Blood 106:2444-2451, 2005 (Pubitemid 41510819)
    • (2005) Blood , vol.106 , Issue.7 , pp. 2444-2451
    • Jarrett, R.F.1    Stark, G.L.2    White, J.3    Angus, B.4    Alexander, F.E.5    Krajewski, A.S.6    Freeland, J.7    Taylor, G.M.8    Taylor, P.R.A.9
  • 150
    • 0028363275 scopus 로고
    • Histopathologic grading of nodular sclerosis Hodgkin's disease: Lack of prognostic significance in 254 surgically staged patients
    • DOI 10.1002/1097-0142(19940715)74:2<708::AID-CNCR2820740226>3.0. CO;2-7
    • Hess JL, Bodis S, Pinkus G, et al: Histopathologic grading of nodular sclerosis Hodgkin's disease: Lack of prognostic significance in 254 surgically staged patients. Cancer 74:708-714, 1994 (Pubitemid 24217638)
    • (1994) Cancer , vol.74 , Issue.2 , pp. 708-714
    • Hess, J.L.1    Bodis, S.2    Pinkus, G.3    Silver, B.4    Mauch, P.5
  • 151
    • 0031040059 scopus 로고    scopus 로고
    • Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's disease for unselected patients, 1972-92
    • van Spronsen DJ, Vrints LW, Hofstra G, et al: Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's disease for unselected patients, 1972-92. Br J Haematol 96:322-327, 1997
    • (1997) Br J Haematol , vol.96 , pp. 322-327
    • Van Spronsen, D.J.1    Vrints, L.W.2    Hofstra, G.3
  • 153
    • 0027880294 scopus 로고
    • Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis
    • Enblad G, Sundstrom C, Glimelius B: Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 11:187-193, 1993 (Pubitemid 24097112)
    • (1993) Hematological Oncology , vol.11 , Issue.4 , pp. 187-193
    • Enblad, G.1    Sundstrom, C.2    Glimelius, B.3
  • 154
    • 0027450261 scopus 로고
    • Hodgkin disease in patients 60 years of age or older: Histologic and clinical features of advanced-stage disease - The Cancer and Leukemia Group B
    • Mir R, Anderson J, Strauchen J, et al: Hodgkin disease in patients 60 years of age or older: Histologic and clinical features of advanced-stage disease - The Cancer and Leukemia Group B. Cancer 71:1857-1866, 1993
    • (1993) Cancer , vol.71 , pp. 1857-1866
    • Mir, R.1    Anderson, J.2    Strauchen, J.3
  • 155
    • 0034839397 scopus 로고    scopus 로고
    • Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease
    • Axdorph U, Porwit-MacDonald A, Grimfors G, et al: Tissue eosinophilia in relation to immuno-pathological and clinical characteristics in Hodgkin's disease. Leuk Lymphoma 42:1055-1065, 2001 (Pubitemid 32827528)
    • (2001) Leukemia and Lymphoma , vol.42 , Issue.5 , pp. 1055-1065
    • Axdorph, U.1    Porwit-Macdonald2    Grimfors, G.3    Bjorkholm, M.4
  • 157
    • 67749106603 scopus 로고    scopus 로고
    • Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: A study of 59 cases
    • Canioni D, Deau-Fischer B, Taupin P, et al: Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: A study of 59 cases. PLoS One 4:e6341, 2009
    • (2009) PLoS One , vol.4
    • Canioni, D.1    Deau-Fischer, B.2    Taupin, P.3
  • 158
    • 0020083643 scopus 로고
    • Hodgkin's disease: A clinicopathologic study of 659 cases
    • Colby TV, Hoppe RT, Warnke RA: Hodgkin's disease: A clinicopathologic study of 659 cases. Cancer 49:1848-1858, 1982
    • (1982) Cancer , vol.49 , pp. 1848-1858
    • Colby, T.V.1    Hoppe, R.T.2    Warnke, R.A.3
  • 159
    • 77956544224 scopus 로고    scopus 로고
    • A molecular risk score based on four functional pathways for advanced classical Hodgkin lymphoma
    • Sánchez-Espiridión B, Montalbán C, López A, et al: A molecular risk score based on four functional pathways for advanced classical Hodgkin lymphoma. Blood 116:e12-e17, 2010
    • (2010) Blood , vol.116
    • Sánchez-Espiridión, B.1    Montalbán, C.2    López, A.3
  • 160
    • 24744438473 scopus 로고    scopus 로고
    • Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
    • Farinha P, Masoudi H, Skinnider BF, et al: Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 106:2169-2174, 2005
    • (2005) Blood , vol.106 , pp. 2169-2174
    • Farinha, P.1    Masoudi, H.2    Skinnider, B.F.3
  • 161
    • 65249135978 scopus 로고    scopus 로고
    • Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma
    • Schreck S, Friebel D, Buettner M, et al: Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma. Hematol Oncol 27:31-39, 2009
    • (2009) Hematol Oncol , vol.27 , pp. 31-39
    • Schreck, S.1    Friebel, D.2    Buettner, M.3
  • 162
    • 70350238332 scopus 로고    scopus 로고
    • Differences in tumor regulatory T-cell localization and activation status impact patient outcome
    • Ménétrier-Caux C, Gobert M, Caux C: Differences in tumor regulatory T-cell localization and activation status impact patient outcome. Cancer Res 69:7895-7898, 2009
    • (2009) Cancer Res , vol.69 , pp. 7895-7898
    • Ménétrier-Caux, C.1    Gobert, M.2    Caux, C.3
  • 163
    • 38949101159 scopus 로고    scopus 로고
    • Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells
    • DOI 10.1158/1078-0432.CCR-07-1246
    • Alvaro T, Lejeune M, García JF, et al: Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells. Clin Cancer Res 14:685-691, 2008 (Pubitemid 351231148)
    • (2008) Clinical Cancer Research , vol.14 , Issue.3 , pp. 685-691
    • Alvaro, T.1    Lejeune, M.2    Garcia, J.F.3    Salvado, M.T.4    Lopez, C.5    Bosch, R.6    Jaen, J.7    Escriva, P.8    Pons, L.E.9
  • 167
    • 0031808140 scopus 로고    scopus 로고
    • Prognostic value of follicular dendritic cells in nodular sclerosing Hodgkin's disease
    • DOI 10.1046/j.1365-2559.1998.t01-1-00418.x
    • Baur AS, Meugé-Moraw C, Michel G, et al: Prognostic value of follicular dendritic cells in nodular sclerosing Hodgkin's disease. Histopathology 32:512-520, 1998 (Pubitemid 28277551)
    • (1998) Histopathology , vol.32 , Issue.6 , pp. 512-520
    • Baur, A.S.1    Meuge-Moraw, C.2    Michel, G.3    Delacretaz, F.4
  • 169
    • 0030744416 scopus 로고    scopus 로고
    • Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease
    • DOI 10.1002/(SICI)1097-0215(19970729)72:3<394::AID-IJC3>3.0.CO;2-K
    • Enblad G, Sandvej K, Lennette E, et al: Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease. Int J Cancer 72: 394-397, 1997 (Pubitemid 27325863)
    • (1997) International Journal of Cancer , vol.72 , Issue.3 , pp. 394-397
    • Enblad, G.1    Sandvej, K.2    Lennette, E.3    Sundstrom, C.4    Klein, G.5    Glimelius, B.6    Pallesen, G.7
  • 172
    • 21344435055 scopus 로고    scopus 로고
    • Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: Potential for a prognostic factor
    • DOI 10.1158/0008-5472.CAN-05-0100
    • Weihrauch MR, Manzke O, Beyer M, et al: Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: Potential for a prognostic factor. Cancer Res 65:5516-5519, 2005 (Pubitemid 40911150)
    • (2005) Cancer Research , vol.65 , Issue.13 , pp. 5516-5519
    • Weihrauch, M.R.1    Manzke, O.2    Beyer, M.3    Haverkamp, H.4    Diehl, V.5    Bohlen, H.6    Wolf, J.7    Schultze, J.L.8
  • 173
    • 0025833281 scopus 로고
    • Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease
    • Gause A, Pohl C, Tschiersch A, et al: Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease. Blood 77:1983-1988, 1991
    • (1991) Blood , vol.77 , pp. 1983-1988
    • Gause, A.1    Pohl, C.2    Tschiersch, A.3
  • 175
    • 0029086042 scopus 로고
    • Soluble ICAM-1 in Hodgkin's disease: A promising independent predictive marker for survival
    • Christiansen I, Enblad G, Kalkner KM, et al: Soluble ICAM-1 in Hodgkin's disease: A promising independent predictive marker for survival. Leuk Lymphoma 19:243-251, 1995
    • (1995) Leuk Lymphoma , vol.19 , pp. 243-251
    • Christiansen, I.1    Enblad, G.2    Kalkner, K.M.3
  • 176
    • 0031840361 scopus 로고    scopus 로고
    • Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease
    • DOI 10.1046/j.1365-2141.1998.00840.x
    • Christiansen I, Sundström C, Enblad G, et al: Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease. Br J Haematol 102:701-709, 1998 (Pubitemid 28387052)
    • (1998) British Journal of Haematology , vol.102 , Issue.3 , pp. 701-709
    • Christiansen, I.1    Sundstrom, C.2    Enblad, G.3    Totterman, T.H.4
  • 178
    • 53349174860 scopus 로고    scopus 로고
    • Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis
    • Brune V, Tiacci E, Pfeil I, et al: Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 205:2251-2268, 2008
    • (2008) J Exp Med , vol.205 , pp. 2251-2268
    • Brune, V.1    Tiacci, E.2    Pfeil, I.3
  • 179
    • 57149089307 scopus 로고    scopus 로고
    • Stromal gene signatures in large B-cell lymphomas
    • Lenz G, Wright G, Dave SS, et al: Stromal gene signatures in large B-cell lymphomas. N Engl J Med 359:2313-2323, 2008
    • (2008) N Engl J Med , vol.359 , pp. 2313-2323
    • Lenz, G.1    Wright, G.2    Dave, S.S.3
  • 180
    • 78649859816 scopus 로고    scopus 로고
    • Vascularization predicts overall survival and risk of transformation in follicular lymphoma
    • Farinha P, Kyle A, Minchinton A, et al: Vascularization predicts overall survival and risk of transformation in follicular lymphoma. Haematologica 95: 2157-2160, 2010
    • (2010) Haematologica , vol.95 , pp. 2157-2160
    • Farinha, P.1    Kyle, A.2    Minchinton, A.3
  • 181
    • 77649206608 scopus 로고    scopus 로고
    • Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
    • Iqbal J, Weisenburger DD, Greiner TC, et al: Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 115: 1026-1036
    • Blood , vol.115 , pp. 1026-1036
    • Iqbal, J.1    Weisenburger, D.D.2    Greiner, T.C.3
  • 184
    • 41949122480 scopus 로고    scopus 로고
    • MicroRNA expression profiling in classic Hodgkin lymphoma
    • Navarro A, Gaya A, Martinez A, et al: MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 111:2825-2832, 2008
    • (2008) Blood , vol.111 , pp. 2825-2832
    • Navarro, A.1    Gaya, A.2    Martinez, A.3
  • 185
    • 70449500709 scopus 로고    scopus 로고
    • Regulation of JAK2 by miR-135a: Prognostic impact in classic Hodgkin lymphoma
    • Navarro A, Diaz T, Martinez A, et al: Regulation of JAK2 by miR-135a: Prognostic impact in classic Hodgkin lymphoma. Blood 114:2945-2951, 2009
    • (2009) Blood , vol.114 , pp. 2945-2951
    • Navarro, A.1    Diaz, T.2    Martinez, A.3
  • 186
    • 77949463615 scopus 로고    scopus 로고
    • Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
    • Younes A: Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 507-519, 2009
    • (2009) Hematology Am Soc Hematol Educ Program , pp. 507-519
    • Younes, A.1
  • 189
    • 38049162295 scopus 로고    scopus 로고
    • Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: Long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
    • Schulz H, Rehwald U, Morschhauser F, et al: Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: Long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). Blood 111:109-111, 2008
    • (2008) Blood , vol.111 , pp. 109-111
    • Schulz, H.1    Rehwald, U.2    Morschhauser, F.3
  • 191
    • 66149155829 scopus 로고    scopus 로고
    • Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma
    • Younes A, Wong F: Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma. Ann Oncol 20:1147-1148, 2009
    • (2009) Ann Oncol , vol.20 , pp. 1147-1148
    • Younes, A.1    Wong, F.2
  • 195
    • 76049122850 scopus 로고    scopus 로고
    • Intracellular activation of SGN-35, a potent anti- CD30 antibody-drug conjugate
    • Okeley NM, Miyamoto JB, Zhang X, et al: Intracellular activation of SGN-35, a potent anti- CD30 antibody-drug conjugate. Clin Cancer Res 16:888-897, 2010
    • (2010) Clin Cancer Res , vol.16 , pp. 888-897
    • Okeley, N.M.1    Miyamoto, J.B.2    Zhang, X.3
  • 196
    • 79955871242 scopus 로고    scopus 로고
    • Multiple complete responses in a phase 1 dose-escalation study of the antibody-drug conjugate SGN-35 in patients with relapsed or refractory CD30-positive lymphomas
    • Presented at the abstr 1006
    • Younes A, Forero-Torres A, Bartlett NL, et al: Multiple complete responses in a phase 1 dose-escalation study of the antibody-drug conjugate SGN-35 in patients with relapsed or refractory CD30-positive lymphomas. Presented at the Annual Meeting of the American Society of Hematology, San Francisco, CA, December 6-9, 2008 (abstr 1006)
    • Annual Meeting of the American Society of Hematology, San Francisco, CA, December 6-9, 2008
    • Younes, A.1    Forero-Torres, A.2    Bartlett, N.L.3
  • 197
    • 24944458177 scopus 로고    scopus 로고
    • Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: Induction of apoptosis and enhancement of doxorubicin- And bortezomib-induced cell death
    • DOI 10.1111/j.1365-2141.2005.05656.x
    • Georgakis GV, Li Y, Humphreys R, et al: Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: Induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death. Br J Haematol 130: 501-510, 2005 (Pubitemid 43899752)
    • (2005) British Journal of Haematology , vol.130 , Issue.4 , pp. 501-510
    • Georgakis, G.V.1    Li, Y.2    Humphreys, R.3    Andreeff, M.4    O'Brien, S.5    Younes, M.6    Carbone, A.7    Albert, V.8    Younes, A.9
  • 198
    • 50949133383 scopus 로고    scopus 로고
    • The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
    • Luqman M, Klabunde S, Lin K, et al: The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells. Blood 112:711-720, 2008
    • (2008) Blood , vol.112 , pp. 711-720
    • Luqman, M.1    Klabunde, S.2    Lin, K.3
  • 200
    • 2442549643 scopus 로고    scopus 로고
    • Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-kappaB Mutations or Activation of the CD30, CD40, and RANK Receptors
    • DOI 10.1158/1078-0432.CCR-03-0494
    • Zheng B, Georgakis GV, Li Y, et al: Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors. Clin Cancer Res 10:3207-3215, 2004 (Pubitemid 38619702)
    • (2004) Clinical Cancer Research , vol.10 , Issue.9 , pp. 3207-3215
    • Zheng, B.1    Georgakis, G.V.2    Li, Y.3    Bharti, A.4    McConkey, D.5    Aggarwal, B.B.6    Younes, A.7
  • 201
    • 32644450349 scopus 로고    scopus 로고
    • Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphoma [2]
    • DOI 10.1182/blood-2005-09-3603
    • Younes A, Pro B, Fayad L: Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphoma. Blood 107: 1731-1732, 2006 (Pubitemid 43242417)
    • (2006) Blood , vol.107 , Issue.4 , pp. 1731-1732
    • Younes, A.1    Pro, B.2    Fayad, L.3
  • 202
    • 34447566086 scopus 로고    scopus 로고
    • Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206
    • DOI 10.1080/10428190701411458, PII 780396333
    • Blum KA, Johnson JL, Niedzwiecki D, et al: Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206. Leuk Lymphoma 48:1313-1319, 2007 (Pubitemid 47079358)
    • (2007) Leukemia and Lymphoma , vol.48 , Issue.7 , pp. 1313-1319
    • Blum, K.A.1    Johnson, J.L.2    Niedzwiecki, D.3    Canellos, G.P.4    Cheson, B.D.5    Bartlett, N.L.6
  • 204
    • 51649092609 scopus 로고    scopus 로고
    • Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
    • Buglio D, Georgakis GV, Hanabuchi S, et al: Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines. Blood 112:1424-1433, 2008
    • (2008) Blood , vol.112 , pp. 1424-1433
    • Buglio, D.1    Georgakis, G.V.2    Hanabuchi, S.3
  • 205
    • 70349640680 scopus 로고    scopus 로고
    • Phase II study of oral panobinostat in patients with relapsed/refractory Hodgkin lymphoma (HL) after high-dose chemotherapy with autologous stem cell transplant
    • suppl 2; abstr 34
    • Younes A, Sureda A, Ben-Yehuda D, et al: Phase II study of oral panobinostat in patients with relapsed/refractory Hodgkin lymphoma (HL) after high-dose chemotherapy with autologous stem cell transplant. Haematologica 94, 2009 (suppl 2; abstr 34)
    • (2009) Haematologica , vol.94
    • Younes, A.1    Sureda, A.2    Ben-Yehuda, D.3
  • 210
    • 46749090038 scopus 로고    scopus 로고
    • Current role of gemcitabine in the treatment of Hodgkin lymphoma
    • DOI 10.1080/10428190801911704, PII 792198621
    • Oki Y, Younes A: Current role of gemcitabine in the treatment of Hodgkin lymphoma. Leuk Lymphoma 49:883-889, 2008 (Pubitemid 351942740)
    • (2008) Leukemia and Lymphoma , vol.49 , Issue.5 , pp. 883-889
    • Oki, Y.1    Younes, A.2
  • 211
    • 44949096473 scopus 로고    scopus 로고
    • Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs
    • Correale P, Del Vecchio MT, La Placa M, et al: Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. J Immunother 31:132-147, 2008
    • (2008) J Immunother , vol.31 , pp. 132-147
    • Correale, P.1    Del Vecchio, M.T.2    La Placa, M.3
  • 213
    • 67651092337 scopus 로고    scopus 로고
    • Circulating clonotypic B cells in classic Hodgkin lymphoma
    • Jones RJ, Gocke CD, Kasamon YL, et al: Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood 113:5920-5926, 2009
    • (2009) Blood , vol.113 , pp. 5920-5926
    • Jones, R.J.1    Gocke, C.D.2    Kasamon, Y.L.3
  • 214
    • 41349086204 scopus 로고    scopus 로고
    • A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies
    • Bartlett NL, Younes A, Carabasi MH, et al: A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies. Blood 111:1848-1854, 2008
    • (2008) Blood , vol.111 , pp. 1848-1854
    • Bartlett, N.L.1    Younes, A.2    Carabasi, M.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.